Eledon Pharmaceuticals (ELDN)
(Delayed Data from NSDQ)
$2.73 USD
-0.01 (-0.36%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $2.66 -0.07 (-2.56%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/22/24 |
---|---|
Current Quarter | -0.31 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | 8.11% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.14 |
Next Year | -0.71 |
EPS (TTM) | -1.38 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 100.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 100.00M |
Low Estimate | NA | NA | NA | 100.00M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.31 | -0.29 | -1.14 | -0.71 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | -0.36 | -0.37 | -1.14 | 0.46 |
High Estimate | -0.23 | -0.18 | -0.79 | 0.46 |
Low Estimate | -0.37 | -0.39 | -1.47 | -1.65 |
Year ago EPS | -0.40 | -0.35 | -1.64 | -1.14 |
Year over Year Growth Est. | 22.50% | 17.14% | 30.49% | 37.85% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.31 | -0.29 | -1.14 | -0.71 |
7 Days Ago | -0.31 | -0.29 | -1.14 | -0.71 |
30 Days Ago | -0.31 | -0.29 | -1.14 | -0.71 |
60 Days Ago | -0.31 | -0.29 | -1.14 | -0.71 |
90 Days Ago | -0.29 | -0.26 | -1.06 | -0.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.31 | -0.29 | -1.14 | -0.71 |
Zacks Consensus Estimate | -0.31 | -0.29 | -1.14 | -0.71 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.29 | -0.35 | -0.40 | NA |
Estimate | -0.37 | -0.38 | -0.41 | -0.47 | NA |
Difference | 0.03 | 0.09 | 0.06 | 0.07 | 0.06 |
Surprise | 8.11% | 23.68% | 14.63% | 14.89% | 15.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more